I was expecting a reacceleration of growth for UiPath in the second half of FY2023 — management expects otherwise. Short-term macro uncertainty and weaker-than-expected guidance led to investors ...

Initiate on UiPath Inc. at Neutral with a $15 PT, citing resilient cloud ARR growth and enterprise customer expansion, but competitive intensity and CEO transition limit near-term upside. FY26E and ...

Palantir’s revenue accelerated again as its profits soared. UiPath’s growth stalled out as it faced macro and competitive challenges. The pricier stock should be the better buy for the foreseeable ...

UiPath Inc. raised its full-year revenue outlook after cruising past Wall Street’s expectations and swinging to a profit in its latest quarterly results, powered by momentum in its artificial ...

Gupta provided Q2 2026 guidance of revenue in the range of $345 million to $350 million and ARR in the range of $1.715 billion to $1.720 billion. Full fiscal year 2026 guidance is revenue of $1.549 ...

UiPath Inc. (NYSE: PATH) was recently added to the S&P MidCap 400 index, replacing Synovus Financial Corp., reflecting the automation company's increased scale and market presence. This index ...

Raimo Lenschow, an analyst from Barclays, maintained the Hold rating on UiPath (PATH – Research Report). The associated price target is $25.00. Raimo Lenschow’s rating is based on UiPath’s performance ...

UiPath (NYSE:PATH) just delivered a quarterly earnings report that turned more than a few heads. The company posted revenue growth and impressive gross margins, which caught the attention not just of ...

Palantir (NYSE: PLTR) and UiPath (NYSE: PATH) represent two different ways to invest in the growing artificial intelligence (AI) market. Palantir mines data from disparate sources to help its ...

Palantir is growing like a weed, but its valuations are getting overheated. UiPath faces tough near-term challenges, but its stock looks a lot cheaper. Both stocks are risky plays in this frothy ...